Puma Biotechnology Inc revenue breakdown overview

Puma Biotechnology Inc revenue for the last year amounted to 235.60 M USD, the most of which — 235.64 M USD — came from its highest performing source at the moment, Cancer Care Products, the year earlier bringing 228.03 M USD. The greatest contribution to the revenue figure was made by United States — last year it brought Puma Biotechnology Inc 235.64 M USD, and the year before that — 228.03 M USD.